At the December 2024 PCAC meeting, the committee evaluated CJC 1295 in multiple forms including the DAC variant
However, 2025 will be anything but, as we will elaborate in this blog
#SubcutaneousInfusion #MedicalDevices #MyastheniaGravis #RYSTIGGO #BiologicTherapy #FDAclearance #InfusionTherapy #RareDiseaseTreatment #ClinicalWorkflow #DrugDeliveryInnovation To view or add a comment, sign in How Dextromethorphan Stops Cough | Doctor Explains Dextromethorphan is a central cough suppressant used mainly for dry cough
Competition intensifies accordingly
Global guidelines generally recommend GLP-1 or GIP/GLP-1 injections for: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related condition , such as: Type 2 diabetes High blood pressure High cholesterol Sleep apnea Fatty liver disease Not suitable for: Pregnant or breastfeeding individuals Anyone with a history of pancreatitis Patients with certain endocrine or thyroid cancers Children/adolescents (unless specifically approved) In Singapore, eligibility is assessed by a licensed doctor based on BMI, metabolic health, and previous response to lifestyle interventions